BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 35226465)

  • 1. Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review.
    Khan MI; Hossain MI; Hossain MK; Rubel MHK; Hossain KM; Mahfuz AMUB; Anik MI
    ACS Appl Bio Mater; 2022 Mar; 5(3):971-1012. PubMed ID: 35226465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs.
    Liu Y; Liang Y; Yuhong J; Xin P; Han JL; Du Y; Yu X; Zhu R; Zhang M; Chen W; Ma Y
    Drug Des Devel Ther; 2024; 18():1469-1495. PubMed ID: 38707615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanostructured materials for applications in drug delivery and tissue engineering.
    Goldberg M; Langer R; Jia X
    J Biomater Sci Polym Ed; 2007; 18(3):241-68. PubMed ID: 17471764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery.
    Torchilin VP
    Nat Rev Drug Discov; 2014 Nov; 13(11):813-27. PubMed ID: 25287120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart Drug-Delivery Systems for Cancer Nanotherapy.
    Sanchez-Moreno P; Ortega-Vinuesa JL; Peula-Garcia JM; Marchal JA; Boulaiz H
    Curr Drug Targets; 2018 Feb; 19(4):339-359. PubMed ID: 27231107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
    Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
    Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Nanoparticles as Anticancer Drug Delivery Vector: Need of this Century.
    Ali I; Mukhtar SD; Ali HS; Scotti MT; Scotti L
    Curr Pharm Des; 2020; 26(15):1637-1649. PubMed ID: 32013826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy.
    Xia W; Tao Z; Zhu B; Zhang W; Liu C; Chen S; Song M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Overview of the Recent Developments and Patents in the Field of Pharmaceutical Nanotechnology.
    Purohit D; Manchanda D; Makhija M; Rathi J; Verma R; Kaushik D; Pandey P
    Recent Pat Nanotechnol; 2021; 15(1):15-34. PubMed ID: 32912128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer chemotherapy with lipid-based nanocarriers.
    Liu D; Zhang N
    Crit Rev Ther Drug Carrier Syst; 2010; 27(5):371-417. PubMed ID: 21083528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration.
    Fonseca-Santos B; Silva PB; Rigon RB; Sato MR; Chorilli M
    Curr Med Chem; 2020; 27(22):3623-3656. PubMed ID: 31232233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies of overcoming the physiological barriers for tumor-targeted nano-sized drug delivery systems.
    Pi Y; Zhou J; Wang J; Zhong J; Zhang L; Wang Y; Yu L; Yan Z
    Curr Pharm Des; 2015; 21(42):6236-45. PubMed ID: 26503142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanostructured Lipid Carriers as Potential Drug Delivery Systems for Skin Disorders.
    Waghule T; Rapalli VK; Gorantla S; Saha RN; Dubey SK; Puri A; Singhvi G
    Curr Pharm Des; 2020; 26(36):4569-4579. PubMed ID: 32534562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapy.
    Selvamuthukumar S; Velmurugan R
    Lipids Health Dis; 2012 Nov; 11():159. PubMed ID: 23167765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-sensitive nanoscale drug delivery systems for cancer treatment.
    Mirhadi E; Mashreghi M; Faal Maleki M; Alavizadeh SH; Arabi L; Badiee A; Jaafari MR
    Int J Pharm; 2020 Nov; 589():119882. PubMed ID: 32941986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregation-induced emission (AIE) fluorophores as imaging tools to trace the biological fate of nano-based drug delivery systems.
    Wang Y; Zhang Y; Wang J; Liang XJ
    Adv Drug Deliv Rev; 2019 Mar; 143():161-176. PubMed ID: 30529308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of
    Wang T; Zhang D; Sun D; Gu J
    J Pharm Anal; 2020 Jun; 10(3):221-232. PubMed ID: 32612868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.